251 related articles for article (PubMed ID: 23135160)
41. Relaxin-3 regulates corticotropin-releasing factor gene expression in cultured rat hypothalamic 4B cells.
Yagi H; Kageyama K; Kinoshita N; Niioka K; Yamagata S; Ito E; Daimon M
Neurosci Lett; 2019 Jan; 692():137-142. PubMed ID: 30412752
[TBL] [Abstract][Full Text] [Related]
42. Alterations of relaxin and its receptor system components in experimental diabetic cardiomyopathy rats.
Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chen W; Ma X; Yin X
Cell Tissue Res; 2017 Nov; 370(2):297-304. PubMed ID: 28776188
[TBL] [Abstract][Full Text] [Related]
43. Differential effects of central administration of relaxin-3 on food intake and hypothalamic neuropeptides in male and female rats.
Calvez J; Lenglos C; de Ávila C; Guèvremont G; Timofeeva E
Genes Brain Behav; 2015 Sep; 14(7):550-63. PubMed ID: 26234422
[TBL] [Abstract][Full Text] [Related]
44. Central relaxin-3 receptor (RXFP3) activation increases ERK phosphorylation in septal cholinergic neurons and impairs spatial working memory.
Albert-Gascó H; García-Avilés Á; Moustafa S; Sánchez-Sarasua S; Gundlach AL; Olucha-Bordonau FE; Sánchez-Pérez AM
Brain Struct Funct; 2017 Jan; 222(1):449-463. PubMed ID: 27146679
[TBL] [Abstract][Full Text] [Related]
45. Discovery and Characterization of the First Nonpeptide Antagonists for the Relaxin-3/RXFP3 System.
Gay EA; Guan D; Van Voorhies K; Vasukuttan V; Mathews KM; Besheer J; Jin C
J Med Chem; 2022 Jun; 65(11):7959-7974. PubMed ID: 35594150
[TBL] [Abstract][Full Text] [Related]
46. Secretory overexpression and isotopic labeling of the chimeric relaxin family peptide R3/I5 in Pichia pastoris.
Guo YQ; Wu QP; Shao XX; Shen T; Liu YL; Xu ZG; Guo ZY
Amino Acids; 2015 Jun; 47(6):1117-25. PubMed ID: 25740604
[TBL] [Abstract][Full Text] [Related]
47. Recent progress in relaxin-3-related research.
Liu C; Bonaventure P; Sutton SW; Chen J; Kuei C; Nepomuceno D; Lovenberg TW
Ann N Y Acad Sci; 2005 May; 1041():47-60. PubMed ID: 15956687
[TBL] [Abstract][Full Text] [Related]
48. Involvement of relaxin-family peptide-3 receptor (RXFP3) in the ventral dentate gyrus of the hippocampus in spatial and fear memory in rats.
Vafaei Z; Khodagholi F; Nategh M; Nikseresht S; Hashemirad SR; Raise-Abdullahi P; Vafaei AA; Motamedi F
Peptides; 2024 Aug; 178():171244. PubMed ID: 38788901
[TBL] [Abstract][Full Text] [Related]
49. Sex-specific effects of relaxin-3 on food intake and body weight gain.
Calvez J; de Ávila C; Timofeeva E
Br J Pharmacol; 2017 May; 174(10):1049-1060. PubMed ID: 27245781
[TBL] [Abstract][Full Text] [Related]
50. Distinct but overlapping binding sites of agonist and antagonist at the relaxin family peptide 3 (RXFP3) receptor.
Wong LLL; Scott DJ; Hossain MA; Kaas Q; Rosengren KJ; Bathgate RAD
J Biol Chem; 2018 Oct; 293(41):15777-15789. PubMed ID: 30131340
[TBL] [Abstract][Full Text] [Related]
51. Minimization of human relaxin-3 leading to high-affinity analogues with increased selectivity for relaxin-family peptide 3 receptor (RXFP3) over RXFP1.
Shabanpoor F; Akhter Hossain M; Ryan PJ; Belgi A; Layfield S; Kocan M; Zhang S; Samuel CS; Gundlach AL; Bathgate RA; Separovic F; Wade JD
J Med Chem; 2012 Feb; 55(4):1671-81. PubMed ID: 22257012
[TBL] [Abstract][Full Text] [Related]
52. Central amygdala relaxin-3/relaxin family peptide receptor 3 signalling modulates alcohol seeking in rats.
Walker LC; Kastman HE; Krstew EV; Gundlach AL; Lawrence AJ
Br J Pharmacol; 2017 Oct; 174(19):3359-3369. PubMed ID: 28726252
[TBL] [Abstract][Full Text] [Related]
53. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135.
Sutton SW; Bonaventure P; Kuei C; Nepomuceno D; Wu J; Zhu J; Lovenberg TW; Liu C
Neuroendocrinology; 2005; 82(3-4):139-50. PubMed ID: 16679775
[TBL] [Abstract][Full Text] [Related]
54. Effects of chronic silencing of relaxin-3 production in nucleus incertus neurons on food intake, body weight, anxiety-like behaviour and limbic brain activity in female rats.
de Ávila C; Chometton S; Ma S; Pedersen LT; Timofeeva E; Cifani C; Gundlach AL
Psychopharmacology (Berl); 2020 Apr; 237(4):1091-1106. PubMed ID: 31897576
[TBL] [Abstract][Full Text] [Related]
55. Cholesterol modulates the binding properties of human relaxin family peptide receptor 3 with its ligands.
Wang JH; Hu MJ; Shao XX; Wei D; Liu YL; Xu ZG; Guo ZY
Arch Biochem Biophys; 2018 May; 646():24-30. PubMed ID: 29601823
[TBL] [Abstract][Full Text] [Related]
56. Sex differences in the effects of chronic stress and food restriction on body weight gain and brain expression of CRF and relaxin-3 in rats.
Lenglos C; Mitra A; Guèvremont G; Timofeeva E
Genes Brain Behav; 2013 Jun; 12(4):370-87. PubMed ID: 23425370
[TBL] [Abstract][Full Text] [Related]
57. Relaxin-3 receptor (RXFP3) activation in the nucleus of the solitary tract modulates respiratory rate and the arterial chemoreceptor reflex in rat.
Furuya WI; Dhingra RR; Gundlach AL; Hossain MA; Dutschmann M
Respir Physiol Neurobiol; 2020 Jan; 271():103310. PubMed ID: 31568840
[TBL] [Abstract][Full Text] [Related]
58. Hydrocarbon stapled B chain analogues of relaxin-3 retain biological activity.
Jayakody T; Marwari S; Lakshminarayanan R; Tan FC; Johannes CW; Dymock BW; Poulsen A; Herr DR; Dawe GS
Peptides; 2016 Oct; 84():44-57. PubMed ID: 27498038
[TBL] [Abstract][Full Text] [Related]
59. Sex- and age-specific differences in relaxin family peptide receptor expression within the hippocampus and amygdala in rats.
Meadows KL; Byrnes EM
Neuroscience; 2015 Jan; 284():337-348. PubMed ID: 25313002
[TBL] [Abstract][Full Text] [Related]
60. Involvement of central relaxin-3 signalling in sodium (salt) appetite.
Smith CM; Walker LL; Chua BE; McKinley MJ; Gundlach AL; Denton DA; Lawrence AJ
Exp Physiol; 2015 Sep; 100(9):1064-72. PubMed ID: 26147879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
